High risk of adverse events in hospitalised hip fracture patients of 65 years and older: results of a retrospective record review study

BMJ Open
Hanneke MertenCordula Wagner

Abstract

Hip fracture patients of 65 years and older are a complex patient group who often suffer from complications and difficult rehabilitation with disappointing results. It is unknown to what extent suboptimal hospital care contributes to these poor outcomes. This study reports on the scale, preventability, causes and prevention strategies of adverse events in patients, aged 65 years and older, admitted to the hospital with a primary diagnosis of hip fracture. A retrospective record review study was conducted of 616 hip fracture patients (≥65 years) admitted to surgical or orthopaedic departments in four Dutch hospitals in 2007. Experienced physician reviewers determined the presence and preventability of adverse events, causes and prevention strategies using a structured review form. The main outcome measures were frequency of adverse events and preventable adverse events in hospitalised hip fracture patients of 65 years and older, and strategies to prevent them in the future. 114 (19%) of the 616 patients in the study experienced one or more adverse events; 49 of these were preventable. The majority of the adverse events (70%) was related to the surgical procedure and many resulted in an intervention or additional treatment (67%)....Continue Reading

References

Nov 6, 1995·The Medical Journal of Australia·R M WilsonJ D Hamilton
Mar 4, 1996·The Medical Journal of Australia·J R Caplehorn
Apr 16, 1999·American Journal of Surgery·S P Harbison, G Regehr
Mar 7, 2001·BMJ : British Medical Journal·C VincentM Woloshynowych
May 26, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·G Ross BakerRobyn Tamblyn
Oct 27, 2004·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Jeannie L CallumHarold S Kaplan
May 13, 2006·Clinical Medicine : Journal of the Royal College of Physicians of London·Graham NealeSisse Olsen
Nov 2, 2007·Medical Education·Karlijn OvereemRichard P T M Grol
Jun 4, 2008·Quality & Safety in Health Care·E N de VriesM A Boermeester
Feb 11, 2009·Quality & Safety in Health Care·J BennC Vincent
Feb 10, 2010·Quality & Safety in Health Care·M SmitsC Wagner
Jan 12, 2011·Indian Journal of Orthopaedics·Dinesh K DhanwalCyrus Cooper
Feb 4, 2012·Dementia and Geriatric Cognitive Disorders·G I RingdalJ H Loge
Dec 3, 2014·Injury·Vasanth SathiyakumarManish K Sethi

❮ Previous
Next ❯

Citations

Apr 18, 2019·The Journal of Bone and Joint Surgery. American Volume·Travis D BloodPeter G Trafton
Dec 1, 2019·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Sandra B LauckUNKNOWN 3M TAVR Investigators, and Nursing and Allied Health Professional Site Leaders
May 23, 2020·International Journal of Orthopaedic and Trauma Nursing·Paula Kelly PetterssonMaria Unbeck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.